Meet the media team
Find a media contact in your region
Learn more
Total 30 Results for:
Showing 12 out of 30 results
1 juin 2026
Herbert Smith Freehills Kramer advises placing agents on CARsgen Therapeutics' HK$470 million Hong Kong share placement
Leading global law firm Herbert Smith Freehills Kramer has advised UBS AG Hong Kong Branch and Macquarie Capital Limited, the joint placing agents to …
15 mai 2026
Herbert Smith Freehills Kewei advises Fosun Pharma on option agreement with AriBio for territories including the US, Europe and Japan
Leading global law firm Herbert Smith Freehills Kramer and its China joint operation partner Kewei have advised China pharmaceutical giant Fosun Pharma …
19 février 2026
Herbert Smith Freehills Kramer advises Morrison on acquisition of SuperFreeze Singapore
Leading international law firm Herbert Smith Freehills Kramer has advised Morrison, a global infrastructure investment firm, on its acquisition of …
12 décembre 2025
Herbert Smith Freehills Kewei advises Fosun Pharma on international licence agreements with Pfizer and Sitala
International leading law firm Herbert Smith Freehills Kramer and its China joint operation partner Kewei have advised China’s pharmaceutical leader …
23 mai 2025
Herbert Smith Freehills advises underwriters on Hengrui's Hong Kong IPO
Leading international law firm Herbert Smith Freehills has advised Morgan Stanley Asia Limited, Citigroup Global Markets Asia Limited, Huatai Financial …
10 juillet 2024
Herbert Smith Freehills advises EQT and Icon Group on its acquisition of the Pharmaxo Group
Leading international law firm Herbert Smith Freehills has advised EQT Partners (EQT), a global investment firm and one of the world's largest private …
13 juin 2024
Herbert Smith Freehills advises sole sponsor and overall coordinators on QuantumPharm's Hong Kong IPO
Leading international law firm Herbert Smith Freehills has advised CITIC Securities (Hong Kong) Limited as the Sole Sponsor and CLSA Limited, China …
15 novembre 2023
Herbert Smith Freehills appoints new Pharma Co-Head
Herbert Smith Freehills has appointed Chris Parker KC as Co-Head of the firm's Pharmaceuticals group.Chris is a partner specialising in international …
1 novembre 2023
Herbert Smith Freehills advises Zydus Lifesciences Limited on acquisition of the UK based LiqMeds Group
Leading international law firm Herbert Smith Freehills has advised Zydus Pharmaceuticals UK Limited, a 100% subsidiary of Indian multinational …
12 juin 2023
Herbert Smith Freehills advises sole sponsor and overall coordinators on Cutia Therapeutics' Hong Kong IPO 史密夫斐尔律师事务所作为独家保荐人和整体协调人律师为科笛集团香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised the sole sponsor and the overall coordinators on Cutia Therapeutics (02487.HK)'s …
15 décembre 2022
Herbert Smith Freehills advises joint sponsors on 3D Medicines' Hong Kong IPO 史密夫斐尔律师事务所作为联席保荐人律师为思路迪香港上市提供法律服务
Leading international law firm Herbert Smith Freehills has advised CICC and CSCI as joint sponsors of 3D Medicines Inc. (01244.HK)’s mainboard listing on …
18 novembre 2022
Herbert Smith Freehills and Hiswara Bunjamin & Tandjung advise Silk Road Fund on investment in Indonesian pharmaceutical SOEs 史密夫斐尔及Hiswara Bunjamin & Tandjung为丝路基金投资印尼国有制药企业提供法律咨询
Leading international law firm Herbert Smith Freehills and its associate firm Hiswara Bunjamin & Tandjung have advised China's Silk Road Fund on a …
Showing 12 out of 30 results
View moreCode≠Law: In a race between innovation and oversight, which one sets the pace?
The second chapter of our series explores the forces shaping AI’s next phase and what they mean for business
Read our latest report